CAM and SACT

  • Research type

    Research Study

  • Full title

    Evaluation of patients’ utilisation, understanding and disclosure of complementary alternative medicines (CAM) whilst receiving systemic anticancer treatment (SACT) and evaluation of the significance of interaction with SACT

  • IRAS ID

    217878

  • Contact name

    Peter Middleton

  • Contact email

    peter.middleton@newcastle.ac.uk

  • Sponsor organisation

    Newcastle University

  • Duration of Study in the UK

    0 years, 1 months, 0 days

  • Research summary

    Many patient treated for cancer perceive complementary alternative medicines CAM as safe and are unaware of the problems that can happen when taken concomitantly with chemotherapy. The research is to find why people try CAM, who advises on their use, and patient awareness, ultimately to inform clinicians of patients behaviour and help prevent any complications. The study will be conducted in the day unit in the Norfolk and Norwich hospital for cancer patient undergoing treatment over the period of 4 weeks.

  • REC name

    West of Scotland REC 5

  • REC reference

    17/WS/0018

  • Date of REC Opinion

    24 Jan 2017

  • REC opinion

    Favourable Opinion